Frank M. Svoboda, Co-Chairman and CEO of Globe Life Inc. (NYSE:GL), recently sold a significant portion of his common stock holdings. According to a filing with the Securities and Exchange Commission, Svoboda sold a total of 13,448 shares on January 6, 2025. The shares were sold at prices ranging from $112.2959 to $113.091 per share, amounting to a total transaction value of approximately $1.51 million. The transaction comes as Globe Life trades at an attractive P/E ratio of 9.4x, with the company maintaining strong profitability as evidenced by its $1.1 billion in net income over the last twelve months.
Additionally, Svoboda exercised stock options to acquire 16,000 shares at a price of $87.60 per share, totaling $1,401,600. Following these transactions, Svoboda holds 18,948 shares directly and has indirect holdings of 144,898 shares in a family trust and 1,931.401 shares in a Thrift/401(k) Plan Trust. The company has demonstrated strong shareholder commitment, maintaining dividend payments for 55 consecutive years with a 6.7% dividend growth in the last year. InvestingPro analysis reveals 8 additional key insights about Globe Life's financial health and market position.
These transactions reflect Svoboda's ongoing management of his equity stake in Globe Life, a company known for its life insurance offerings and currently valued at $9.4 billion market capitalization.
In other recent news, Globe Life Inc. has experienced several significant developments. The company reported robust Q3 2024 financial results, with net income rising to $303 million and a 29% increase in net operating income to $308 million. Following these results, Truist Securities revised its earnings per share estimates for 2024 and 2025, leading to a price target increase to $105.00.
Globe Life also responded to a critical report by Viceroy Research, asserting the claims were unfounded and emphasizing its successful shift to a virtual business model for its subsidiary, American Income Life (AIL). The company reported a revenue increase of 6.7% over the last twelve months, attributed to the expansion of AIL's agent workforce and increased policy issuance.
Additionally, TD Cowen reaffirmed its confidence in Globe Life, maintaining a Buy rating and a price target of $150.00. This endorsement follows a positive outlook expressed by Globe Life's management regarding ongoing regulatory inquiries and the performance of the company's core business.
The company also introduced an executive severance plan covering scenarios involving the termination of the company's Co-CEOs and other Named Executive Officers, as detailed in a recent SEC 8-K filing. Furthermore, Globe Life expanded its stock buyback program to $1.8 billion, highlighting its commitment to optimizing shareholder value. These are the recent developments surrounding Globe Life Inc.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.